Literature DB >> 8003860

The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum.

Y Abe1, Y Watanabe, S Kimura.   

Abstract

Two types of tumor necrosis factor membrane receptors (TNF-R) have been identified, namely 55 and 75 kDa TNF-R. Soluble forms of these receptors are present in the human serum. Recent findings on the role of these two TNF-R in biological cell signaling and the clinical significance of the serum levels of soluble TNF-R (sTNF-R) were reviewed. It is not the uptake of TNF molecules into cells but rather the molecular capping of TNF-R on the cell membrane that initiates the biological activity of TNF. The 55 kDa TNF-R mediates major bioactivities of TNF, while the significance of 75 kDa TNF-R remains unclear. We herein suggest a new concept of the role of these two TNF-R: The 75 kDa TNF-R signal appeared to enhance that of 55 kDa TNF-R in the induction of ICAM-1 expression on HL-60 human promyelocytic leukemic cells. High serum levels of sTNF-R are reported in patients with malignancy, endotoxin shock, pneumonia, and autoimmune diseases. However, the source of elevated serum sTNF-R remains unclear. Studies on the clinical usefulness of serum sTNF-R levels as cancer and inflammation markers are now being carried out.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8003860     DOI: 10.1007/BF02032887

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  52 in total

Review 1.  Tumour necrosis factor. Another chapter in the long history of endotoxin.

Authors:  L J Old
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

2.  Molecular cloning and expression of a receptor for human tumor necrosis factor.

Authors:  T J Schall; M Lewis; K J Koller; A Lee; G C Rice; G H Wong; T Gatanaga; G A Granger; R Lentz; H Raab
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

3.  Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients.

Authors:  T Gatanaga; R Lentz; I Masunaka; J Tomich; E W Jeffes; M Baird; G A Granger
Journal:  Lymphokine Res       Date:  1990

4.  Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.

Authors:  M Lewis; L A Tartaglia; A Lee; G L Bennett; G C Rice; G H Wong; E Y Chen; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

5.  Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity.

Authors:  G R Adolf; B Frühbeis
Journal:  Cytokine       Date:  1992-05       Impact factor: 3.861

6.  Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.

Authors:  E Girardin; P Roux-Lombard; G E Grau; P Suter; H Gallati; J M Dayer
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

7.  Human TNF mutants with selective activity on the p55 receptor.

Authors:  X Van Ostade; P Vandenabeele; B Everaerdt; H Loetscher; R Gentz; M Brockhaus; W Lesslauer; J Tavernier; P Brouckaert; W Fiers
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

8.  A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids.

Authors:  G R Adolf; I Apfler
Journal:  J Immunol Methods       Date:  1991-09-20       Impact factor: 2.303

9.  Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha.

Authors:  S Yokota; T D Geppert; P E Lipsky
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

10.  Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.

Authors:  J S Andrews; A E Berger; C F Ware
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

View more
  3 in total

1.  Soluble tumor necrosis factor alpha receptors (sTNF-Rs) in HIV-1-infected intravenous drug users: change in circulating sTNF-R type II level and survival for AIDS patients.

Authors:  F Ajello; R La Licata; M Lodato; F Vitale; F Bonura; R Valenti; M Bruno; N Romano
Journal:  Eur J Epidemiol       Date:  2000-03       Impact factor: 8.082

2.  Effect of tumour necrosis factor-alpha receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept.

Authors:  E Mazzon; E Esposito; R Di Paola; C Muià; C Crisafulli; T Genovese; R Caminiti; R Meli; P Bramanti; S Cuzzocrea
Journal:  Clin Exp Immunol       Date:  2008-05-26       Impact factor: 4.330

3.  Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation.

Authors:  Emanuela Mazzon; Salvatore Cuzzocrea
Journal:  Respir Res       Date:  2007-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.